CYP 3A4 - inhibitoren erythromycin påvirker ikke risperidons farmakokinetik eller den aktive antipsykotiske fraktion.
Erythromycin, a CYP 3A4 inhibitor, does not change the pharmacokinetics of risperidone and the active antipsychotic fraction.